Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Diagnostics and Medical Technology›Diagnostic Imaging

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Diagnostic Imaging

Diagnostics and Medical Technology · NLM MeSH · updated 2026-11-04 · version 1

Citations verified against PubMedNot yet clinician-reviewed9 referencesApproximately 4 min read

Any visual display of structural or functional patterns of organs or tissues for diagnostic evaluation.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. Full-text reviews7. References8. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 3 complete abstracts (680 words), 9 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

Any visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Imaging, Diagnostic; Medical Imaging; Imaging, Medical.

Where it fits in the MeSH classification

Broader topics
Diagnostic Techniques and Procedures
Narrower topics
Cardiac Imaging Techniques; Dacryocystography; Forensic Imaging; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Microscopy; Microwave Imaging; Molecular Imaging; Multimodal Imaging; Neuroimaging; Optical Imaging; Photography; Postmortem Imaging; Radiography
See also
Image Processing, Computer-Assisted; Phantoms, Imaging

Research landscape

PubMed indexes 3,173,852 records tagged with the MeSH heading “Diagnostic Imaging” (counts retrieved 2026-11-04). 534,686 of them (16.8%) were published from 2020 onward, and the busiest period so far is through 1999 with 1,013,015 records.

Reviews account for 263,782 records (8.3%) and meta-analyses for 14,554. Randomized controlled trials number 50,762 (1.6%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 1,013,015 records; 2000-2009: 659,904 records; 2010-2019: 966,247 records; 2020 onward: 534,686 records1,013,015through 1999659,9042000-2009966,2472010-2019534,6862020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19991,013,015
2000-2009659,904
2010-2019966,247
2020 onward534,686
Share of records by publication typeReviews: 8.3 percent; Meta-analyses: 0.5 percent; Randomized controlled trials: 1.6 percentReviews8.3% (263,782)Meta-analyses0.5% (14,554)Randomized controlled trials1.6% (50,762)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 3,173,852 PubMed records
TypeRecordsShare
Reviews263,7828.3%
Meta-analyses14,5540.5%
Randomized controlled trials50,7621.6%

Method: PubMed query "Diagnostic Imaging"[MeSH Terms] with publication-type and date filters, retrieved 2026-11-04.

Reading the evidence in diagnostics and medical technology

A test or device is judged by how well it detects a condition, how often it gives false alarms or misses cases, and whether using it improves outcomes for people. Accuracy depends on who is tested and how common the condition is, so a test that performs well in a specialist hospital can perform differently in the community. Check the reference standard, the population studied, the sensitivity and specificity and whether results were confirmed in a separate group.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Characterization of the Trimeric TOM Complex by HS-AFM Single-Molecule Analysis
Kobayashi N, Omura SN, Kuzasa K, Imai K, Kawai S, Imai H, et al.
2026Research article
Design not recorded in structured metadata
1cc by
PMID 42920373 · DOI · PMC13695020
Can Spleen T1 Mapping Be Used as a Marker of Adenosine Response in Cardiac MRI?
Solis-Barquero SM, Ezponda A, Aramendía-Vidaurreta V, Vidorreta M, Pascual M, Bastarrika G, et al.
2026Research article
Design not recorded in structured metadata
0cc by
PMID 42956826 · DOI · PMC13719266
Copper-Mediated Radiofluorination of the Excitatory Amino Acid Transporter 2 (EAAT2)-Targeted PET Tracer [18F]RP-115: Alternate Synthetic Method
Lee SH, Blecha J, Kim JM, Nillo RM, Flavell RR, Chao CK, et al.
2026Research article
Design not recorded in structured metadata
0cc by
PMID 42952031 · DOI · PMC13716918

Characterization of the Trimeric TOM Complex by HS-AFM Single-Molecule Analysis [1]

Research article Kobayashi N, Omura SN, Kuzasa K, Imai K, Kawai S, Imai H, et al. · · 2026 · cited 1 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The translocase of the outer mitochondrial membrane (TOM) complex is the entry gate for mitochondrial proteins synthesized in the cytosol.
Closing excerpt
Together, these findings provide quantitative and structural evidence for a predominantly trimeric organization of the purified TOM complex and suggest that the trimer contains a stable core-dimer unit with a more loosely associated third Tom40-containing unit.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (198 words)

The translocase of the outer mitochondrial membrane (TOM) complex is the entry gate for mitochondrial proteins synthesized in the cytosol. Previous biochemical studies indicated that the TOM complex functions as a trimer and exists in a dynamic equilibrium with a Tom22-lacking dimer in intact mitochondria. In contrast, recent cryo-electron microscopy (cryo-EM) studies revealed near-atomic structures of the Tom22-containing core dimer. However, the relationship between the core dimer and the functional trimer remains unclear. Here, we analyzed the oligomeric organization and structural properties of purified yeast TOM complexes using high-speed atomic force microscopy (HS-AFM). Purified yeast TOM complexes predominantly adopted a trimeric organization but underwent deformation and dissociation during repeated HS-AFM scanning, leaving dimeric and monomeric particles. Trimeric particles exhibited spherical shapes consistent with previous crosslinking models, whereas dissociated dimers closely resembled TOM core-dimer structures determined by cryo-EM. HS-AFM also revealed the peripheral localization of the Tom20 receptor and enabled direct visualization of substrate-TOM interactions, with TOM association accompanied by reduced substrate mobility. Together, these findings provide quantitative and structural evidence for a predominantly trimeric organization of the purified TOM complex and suggest that the trimer contains a stable core-dimer unit with a more loosely associated third Tom40-containing unit.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42920373 · DOI · PMC13695020

Can Spleen T1 Mapping Be Used as a Marker of Adenosine Response in Cardiac MRI? [2]

Research article Solis-Barquero SM, Ezponda A, Aramendía-Vidaurreta V, Vidorreta M, Pascual M, Bastarrika G, et al. · · 2026

Abstract reading summary — source excerpts
Opening excerpt
Splenic switch-off, defined as the visible reduction in splenic perfusion during adenosine stress, can be used as a marker of adequate adenosine response in cardiac stress MRI studies, which can be assessed after the study.
Closing excerpt
This work indicates that the splenic T1 value change has the potential to identify splenic switch-off during adenosine stress CMR in a clinical population.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (289 words)

Splenic switch-off, defined as the visible reduction in splenic perfusion during adenosine stress, can be used as a marker of adequate adenosine response in cardiac stress MRI studies, which can be assessed after the study. Moreover, there is some evidence regarding the use of T1 mapping for the evaluation of splenic switch-off during the study. The aim of this work is to further investigate splenic T1 mapping as a method for quantitatively assessing splenic switch-off, given the limited existing data. Patients with suspected coronary artery disease were scanned at 1.5 T with the routine clinical protocol for stress perfusion cardiac magnetic resonance (CMR), including a T1 mapping sequence at rest and during adenosine stress. Visual assessment of first-pass images was used as the reference standard for detecting splenic switch-off. Semi-quantitative analysis of splenic perfusion was performed based on the signal intensity curves and signal changes (ΔSI) were calculated. T1 maps were used to obtain T1 value changes in the spleen from rest to stress (ΔT1spleen). Statistical analysis was assessed using an align rank transform followed by a mixed analysis of variance, with Bonferroni corrected post hoc tests. A total of 74.5% (n = 35/47) of analyzed patients experienced splenic switch-off according to the visual assessment. Statistically significant differences were found in splenic T1 between rest and stress only in the switch-off group (p s = 0.37, p = 0.01) between splenic ΔT1 and ΔSI based on first-pass. ROC curves demonstrated that ΔT1spleen classified the failed switch-off and positive switch-off groups with a specificity of 75% and a sensitivity of 80% (AUC: 81.2%, 95% CI: 66.7%-95.8%). This work indicates that the splenic T1 value change has the potential to identify splenic switch-off during adenosine stress CMR in a clinical population.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42956826 · DOI · PMC13719266

Copper-Mediated Radiofluorination of the Excitatory Amino Acid Transporter 2 (EAAT2)-Targeted PET Tracer [18F]RP-115: Alternate Synthetic Method [3]

Research article Lee SH, Blecha J, Kim JM, Nillo RM, Flavell RR, Chao CK, et al. · · 2026

Abstract reading summary — source excerpts
Opening excerpt
Excitatory amino acid transporter 2 (EAAT2) is a key regulator of extracellular glutamate in the central nervous system.
Closing excerpt
This efficient synthesis may serve as a basis for the future implementation of a CMRF-based automated radiosynthesis of [18F]RP-115.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (193 words)

Excitatory amino acid transporter 2 (EAAT2) is a key regulator of extracellular glutamate in the central nervous system. Dysregulated EAAT2 is implicated in neurodegenerative diseases such as Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS), highlighting EAAT2 as a potential target for PET imaging. We previously reported a multistep radiosynthesis of [18F]RP-115, a CNS-permeable prodrug that undergoes esterase-mediated hydrolysis in the CNS to yield the active EAAT2-binding carboxylate. Motivated by recent advances in copper-mediated radiofluorination (CMRF), we sought to develop a more efficient late-stage radiosynthesis of [18F]RP-115. A two-step radiosynthesis of [18F]RP-115 using CMRF provided [18F]RP-115 in high radiochemical yield (52.8% ± 2.1 %, decay-corrected from starting [18F]fluoride ion, n = 4), high molar activity (355 ± 61 GBq/μmol), and high radiochemical purity (> 99%) with a total synthesis time of 70 min. Chiral HPLC analysis demonstrated that the configuration of the aspartic acid residue remained intact without racemization during both the CMRF and trifluoroacetic acid mediated deprotection. We developed an efficient radiosynthesis of [18F]RP-115 via CMRF, achieving high radiochemical yield and molar activity. This efficient synthesis may serve as a basis for the future implementation of a CMRF-based automated radiosynthesis of [18F]RP-115.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42952031 · DOI · PMC13716918

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Radiomics-based artificial intelligence models in brain tumors: A systematic review and meta-analysis of diagnostic performance [4]
    Reyes JS, Almeida T, Bouras A, Mettenburg J, Niranjan A, Lunsford LD, et al. · Neuroradiology · 2026 · cited 8 times (Europe PMC)
  • Research article Validation of magnetic resonance imaging for quantification of intrapancreatic fat deposition using phantom and histologic comparators: a systematic review and meta-analysis [5]
    Zhang J, Liu Y, Petrov MS · Eur Radiol · 2026 · cited 6 times (Europe PMC)
  • Research article Diagnostic Performance of Biparametric versus Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis: An Updated Systematic Review and Meta-analysis [6]
    Strieder de Oliveira G, Altmayer S, Torri GB, Prediger JE, Abreu-Gomez J, Ghai S, et al. · Eur Urol · 2026 · cited 6 times (Europe PMC)
  • Research article Prospective Evidence on Artificial Intelligence-Assisted Melanoma Diagnostics: A Systematic Review and Meta-Analysis [7]
    Laiouar-Pedari S, Kühn A, Wies C, Garcia CN, Winterstein JT, Heinlein L, et al. · JAMA Dermatol · 2026 · cited 3 times (Europe PMC)
  • Research article Diagnostic utility of quantitative susceptibility mapping in Parkinson's disease and atypical parkinsonism: A systematic review and meta-analysis [8]
    Tahamtan M, Kolahi S, Vahidi M, Rezvani A, Radmard M, Firouznia K, et al. · Neuroimage · 2026 · cited 3 times (Europe PMC)
  • Research article Diagnostic Performance and Safety of Endobronchial Ultrasound-Guided Sampling for Mediastinal/Hilar Lymphadenopathy: A Systematic Review and Network Meta-analysis [9]
    Lyu S, Zheng Z, Guo J, Yu X, Feng X, Deng M, et al. · Lung · 2026 · cited 3 times (Europe PMC)

Full-text reviews on EvidenceLib

Open-access review articles about this topic, reproduced in full with authors, licence and references.

  • Artificial Intelligence in Clinical Medicine: Challenges Across Diagnostic Imaging, Clinical Decision Support, Surgery, Pathology, and Drug Discovery

    Eren Ogut, Athanassios A Kyrgidis · Clinics and Practice 2025 · CC BY 4.0

  • Line-Field Confocal Optical Coherence Tomography: A New Skin Imaging Technique Reproducing a “Virtual Biopsy” with Evolving Clinical Applications in Dermatology

    Simone Cappilli, Andrea Paradisi, Alessandro Di Stefani et al. · Diagnostics 2024 · CC BY 4.0

  • Medical Micro/Nanorobots in Precision Medicine

    Fernando Soto, Jie Wang, Rajib Ahmed et al. · Advanced Science 2020 · CC BY 4.0

References

  1. Kobayashi N, Omura SN, Kuzasa K, Imai K, Kawai S, Imai H, et al.. Characterization of the Trimeric TOM Complex by HS-AFM Single-Molecule Analysis. . 2026. PMID 42920373 · DOI · PMC13695020
  2. Solis-Barquero SM, Ezponda A, Aramendía-Vidaurreta V, Vidorreta M, Pascual M, Bastarrika G, et al.. Can Spleen T1 Mapping Be Used as a Marker of Adenosine Response in Cardiac MRI?. . 2026. PMID 42956826 · DOI · PMC13719266
  3. Lee SH, Blecha J, Kim JM, Nillo RM, Flavell RR, Chao CK, et al.. Copper-Mediated Radiofluorination of the Excitatory Amino Acid Transporter 2 (EAAT2)-Targeted PET Tracer [18F]RP-115: Alternate Synthetic Method. . 2026. PMID 42952031 · DOI · PMC13716918
  4. Reyes JS, Almeida T, Bouras A, Mettenburg J, Niranjan A, Lunsford LD, et al.. Radiomics-based artificial intelligence models in brain tumors: A systematic review and meta-analysis of diagnostic performance. Neuroradiology. 2026. PMID 42043503 · DOI
  5. Zhang J, Liu Y, Petrov MS. Validation of magnetic resonance imaging for quantification of intrapancreatic fat deposition using phantom and histologic comparators: a systematic review and meta-analysis. Eur Radiol. 2026. PMID 41872343 · DOI · PMC13341726
  6. Strieder de Oliveira G, Altmayer S, Torri GB, Prediger JE, Abreu-Gomez J, Ghai S, et al.. Diagnostic Performance of Biparametric versus Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis: An Updated Systematic Review and Meta-analysis. Eur Urol. 2026. PMID 41702800 · DOI
  7. Laiouar-Pedari S, Kühn A, Wies C, Garcia CN, Winterstein JT, Heinlein L, et al.. Prospective Evidence on Artificial Intelligence-Assisted Melanoma Diagnostics: A Systematic Review and Meta-Analysis. JAMA Dermatol. 2026. PMID 41879756 · DOI · PMC13019344
  8. Tahamtan M, Kolahi S, Vahidi M, Rezvani A, Radmard M, Firouznia K, et al.. Diagnostic utility of quantitative susceptibility mapping in Parkinson's disease and atypical parkinsonism: A systematic review and meta-analysis. Neuroimage. 2026. PMID 42035898 · DOI
  9. Lyu S, Zheng Z, Guo J, Yu X, Feng X, Deng M, et al.. Diagnostic Performance and Safety of Endobronchial Ultrasound-Guided Sampling for Mediastinal/Hilar Lymphadenopathy: A Systematic Review and Network Meta-analysis. Lung. 2026. PMID 42045698 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-11-04; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-11-04.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Perfusion ImagingDiagnostics and Medical Technology
  • Time-Lapse ImagingDiagnostics and Medical Technology
  • Myocardial Perfusion ImagingDiagnostics and Medical Technology
  • Narrow Band ImagingDiagnostics and Medical Technology
  • Multimodal ImagingDiagnostics and Medical Technology
  • NeuroimagingDiagnostics and Medical Technology

All 110 articles in Diagnostics and Medical Technology →

At a glance

3,173,852
PubMed records on this heading
17%
published since 2020
263,782
review articles
50,762
randomized trials
9
verified references below

Counts come from PubMed on 2026-11-04; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Perfusion ImagingDiagnostics and Medical Technology
  • Time-Lapse ImagingDiagnostics and Medical Technology
  • Myocardial Perfusion ImagingDiagnostics and Medical Technology
  • Narrow Band ImagingDiagnostics and Medical Technology
  • Multimodal ImagingDiagnostics and Medical Technology

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support